This inventor holds 1 USPTO granted patent. Top assignee: Beijing Kwinbon Biotechnology Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovation in Detection: The Invention of Nianqin Xu
Introduction: Nianqin Xu, an esteemed inventor based in Beijing, China, has made significant contributions to the field of biotechnology with his innovative approach to detecting dinitolmide. His work is characterized by a commitment to developing practical and efficient solutions that address critical needs in the industry.
Latest Patents: Nianqin Xu holds a patent for an "Enzyme-linked immunosorbent assay kit for detecting dinitolmide and use thereof." This invention features a kit that includes a dinitolmide antibody, coating antigen, and enzyme conjugate. The dinitolmide antibody can be either a monoclonal or polyclonal antibody. The kit offers simplicity and convenience, making it portable and cost-effective, while ensuring high accuracy and effectiveness in detection. This innovative product is suitable for both qualitative and quantitative screenings, making it ideal for on-site monitoring of dinitolmide levels.
Career Highlights: Xu is associated with Beijing Kwinbon Biotechnology Co., Ltd., where he employs his expertise to develop groundbreaking solutions. His work not only highlights his innovative capabilities but also showcases a dedication to advancing the biotechnology sector.
Collaborations: During his career, Nianqin Xu has collaborated with notable professionals such as Fangyang He and Yuping Wan. These partnerships emphasize the collaborative nature of innovation and the importance of teamwork in achieving groundbreaking results.
Conclusion: Nianqin Xu's contributions to the field of biotechnology, particularly through his patented enzyme-linked immunosorbent assay kit, demonstrate his commitment to innovation. His work plays a crucial role in enhancing the detection of dinitolmide, thereby potentially improving the standards of monitoring in various applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile